title: Two purified domains of telomerase reverse transcriptase reconstitute sequence-specific interactions with RNA.
abstract: Telomerase reverse transcriptase (TERT) and telomerase RNA (TER) function together to create a uniquely specialized polymerase. Here we have described for the first time domains of bacterially expressed Tetrahymena TERT that interacted directly with TER in the absence of assembly chaperones. We used quantitative binding assays to define TER sequence requirements for recognition by the high affinity RNA binding domain and an independent N-terminal RNA interaction domain. The TERT RNA binding domain and N-terminal RNA interaction domain had distinct, nonoverlapping requirements for TER sequence and structure that together accounted for all of the sites of TER contact inferred for full-length TERT. The TER residues important for TERT binding are only a subset of the residues required for catalytic activity. Our findings demonstrate telomerase functional specialization by an elaborate ribonucleoprotein architecture physically separable from the active site.
authors.affiliation: Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3204, USA.
authors.forename: Catherine M
authors.initials: CM
authors.lastname: O'Connor
authors.forename: Cary K
authors.initials: CK
authors.lastname: Lai
authors.forename: Kathleen
authors.initials: K
authors.lastname: Collins
mesh_terms: D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D002384:Catalysis; D020134:Catalytic Domain; D004268:DNA-Binding Proteins; D008957:Models, Genetic; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D011485:Protein Binding; D011487:Protein Conformation; D017434:Protein Structure, Tertiary; D012313:RNA / Q000737:chemistry*; D019098:Telomerase / Q000737:chemistry*; D013768:Tetrahymena
chemical_list: D004268:DNA-Binding Proteins; C422952:telomerase RNA; D012313:RNA; D019098:Telomerase
references.citation: Cell. 2004 Jan 23;116(2):273-9
references.pmid: 14744437
references.citation: Trends Biochem Sci. 2002 Nov;27(11):572-9
references.pmid: 12417133
references.citation: Genes Dev. 1999 Nov 1;13(21):2863-74
references.pmid: 10557213
references.citation: Mol Cell Biol. 2001 Sep;21(18):6151-60
references.pmid: 11509658
references.citation: Oncogene. 2002 Jan 21;21(4):564-79
references.pmid: 11850781
references.citation: Biochemistry. 2001 Jun 19;40(24):7005-16
references.pmid: 11401544
references.citation: Genes Dev. 1995 Sep 15;9(18):2227-39
references.pmid: 7557377
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6585-90
references.pmid: 11997465
references.citation: Mol Cell Biol. 2001 Feb;21(4):990-1000
references.pmid: 11158287
references.citation: RNA. 1995 Jun;1(4):363-74
references.pmid: 7493315
references.citation: Lancet. 2003 Sep 20;362(9388):983-8
references.pmid: 14511933
references.citation: Genes Dev. 2004 May 15;18(10):1107-18
references.pmid: 15131081
references.citation: Cancer Lett. 2003 May 15;194(2):139-54
references.pmid: 12757972
references.citation: Mol Cell. 2003 Jun;11(6):1673-83
references.pmid: 12820978
references.citation: Nucleic Acids Res. 1995 Apr 11;23(7):1091-7
references.pmid: 7739888
references.citation: Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29;359(1441):109-21
references.pmid: 15065663
references.citation: Nat Genet. 1997 Dec;17(4):498-502
references.pmid: 9398860
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8485-90
references.pmid: 9671704
references.citation: Genes Dev. 2002 Feb 15;16(4):415-20
references.pmid: 11850404
references.citation: Mol Cell Biol. 2000 Jul;20(14):5196-207
references.pmid: 10866675
references.citation: Trends Biochem Sci. 2004 Apr;29(4):183-92
references.pmid: 15082312
references.citation: Cancer Cell. 2002 Oct;2(4):257-65
references.pmid: 12398889
references.citation: Genes Dev. 1999 May 1;13(9):1116-25
references.pmid: 10323863
references.citation: Mol Cell Biol. 2002 Feb;22(4):1253-65
references.pmid: 11809815